GB201903953D0 - Oral GLP receptor agonists - Google Patents
Oral GLP receptor agonistsInfo
- Publication number
- GB201903953D0 GB201903953D0 GBGB1903953.6A GB201903953A GB201903953D0 GB 201903953 D0 GB201903953 D0 GB 201903953D0 GB 201903953 A GB201903953 A GB 201903953A GB 201903953 D0 GB201903953 D0 GB 201903953D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- receptor agonists
- oral glp
- glp receptor
- oral
- agonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1903953.6A GB201903953D0 (en) | 2019-03-22 | 2019-03-22 | Oral GLP receptor agonists |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1903953.6A GB201903953D0 (en) | 2019-03-22 | 2019-03-22 | Oral GLP receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201903953D0 true GB201903953D0 (en) | 2019-05-08 |
Family
ID=66381528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1903953.6A Ceased GB201903953D0 (en) | 2019-03-22 | 2019-03-22 | Oral GLP receptor agonists |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201903953D0 (en) |
-
2019
- 2019-03-22 GB GBGB1903953.6A patent/GB201903953D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL282076A (en) | Thyroid hormone receptor agonists | |
IL288921A (en) | Melanocortin-4 receptor agonists | |
IL279300A (en) | Glp-1 receptor agonists and uses thereof | |
IL279224A (en) | Glp-1 receptor agonists and uses thereof | |
IL280290A (en) | Il2 agonists | |
EP3650449A4 (en) | Fxr receptor agonist | |
ZA202102263B (en) | Oral formulations of kappa opioid receptor agonists | |
IL292601A (en) | Npy2 receptor agonists | |
GB201911187D0 (en) | Receptor | |
IL288536A (en) | Il2 agonists | |
IL280199A (en) | Receptor for vista | |
GB201816639D0 (en) | GLP-1 Receptor Antagonist | |
GB201903951D0 (en) | Oral GLP receptor agonists | |
GB201903953D0 (en) | Oral GLP receptor agonists | |
GB201903900D0 (en) | Adenosine receptor agonists | |
GB201816637D0 (en) | Selective somatostatin receptor agonists | |
EP3904374A4 (en) | T-cell receptor modified object | |
GB201903985D0 (en) | GLP receptor agonists | |
GB202003766D0 (en) | Oral GLP receptor agonists | |
GB202003764D0 (en) | Oral GLP receptor agonists | |
GB202003762D0 (en) | GLP receptor agonists | |
GB201817943D0 (en) | Galanin-2 receptor agonists | |
GB201914767D0 (en) | Linear apelin receptor agonists | |
GB201914756D0 (en) | Cyclic apelin receptor agonists | |
GB201910515D0 (en) | GLP-1 Receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |